19-57640868-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006385.5(ZNF211):āc.421C>Gā(p.His141Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000176 in 1,614,208 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006385.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF211 | NM_006385.5 | c.421C>G | p.His141Asp | missense_variant | 4/4 | ENST00000240731.5 | NP_006376.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF211 | ENST00000240731.5 | c.421C>G | p.His141Asp | missense_variant | 4/4 | 2 | NM_006385.5 | ENSP00000240731.4 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000374 AC: 94AN: 251422Hom.: 1 AF XY: 0.000515 AC XY: 70AN XY: 135882
GnomAD4 exome AF: 0.000187 AC: 274AN: 1461890Hom.: 1 Cov.: 32 AF XY: 0.000281 AC XY: 204AN XY: 727246
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2023 | The c.421C>G (p.H141D) alteration is located in exon 4 (coding exon 4) of the ZNF211 gene. This alteration results from a C to G substitution at nucleotide position 421, causing the histidine (H) at amino acid position 141 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at